Elsevier Inc.

SHERPA: Unknown

People

  1. Gelblum
    Gelblum
  2. Wu
    Wu
  3. Chaft
    Chaft
  4. Gomez
    Gomez
  5. Shepherd
    Shepherd
  6. Deasy
    Deasy
  7. Offin
    Offin
  8. Shaverdian
    Shaverdian
  9. Thor
    Thor
  10. Apte
    Apte

Groups

  1. Department of Medicine (17)
  2. Radiation Oncology, Department of (17)
  3. Sloan Kettering Institute Postdocs (17)
  4. Solid Tumor Oncology Division (17)
  5. Thoracic Oncology (14)
  6. Medical Physics (11)
  7. Population Sciences Research Program (7)
  8. Radiotherapy Physics Service (7)
  9. Surgery (7)
  10. Biostatistics Service (5)
Search Within
  1. "Daphna Gelblum"
  2. "Radiation Oncology, Department of"
  3. "Sloan Kettering Institute Postdocs"
  4. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (4)
Groups
  1. Department of Medicine (17)
  2. Radiation Oncology, Department of (17)
  3. Sloan Kettering Institute Postdocs (17)
  4. Solid Tumor Oncology Division (17)
  5. Thoracic Oncology (14)
  6. Medical Physics (11)

More Groups

People
  1. Daphna Gelblum (17)
  2. Andreas Rimner (14)
  3. Abraham Wu (13)
  4. Jamie Chaft (11)
  5. Annemarie Shepherd (8)
  6. Daniel Gomez (8)

More People

Years
  1. 2024 (3)
  2. 2023 (1)
  3. 2022 (5)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (14)
  2. Radiotherapy and Oncology (2)
  3. Clinical Lung Cancer (1)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study evaluating selective minimal residual disease directed adjuvant radiation in human papilloma virus associated oropharynx carcinoma
    Meeting Abstract

    Chen, L.; Cohen, M.; Hatzoglou, V.; Zhang, Z.; Ganly, I.; Boyle, J. O.; Singh, B.; Morris, L. G.; Wong, R. J.; Cracchiolo, J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Randomized clinical trial of tele-surveillance and remote symptom monitoring compared to standard surveillance for HPV-associated oropharynx cancer with no evidence of disease on post-treatment imaging
    Meeting Abstract

    Zakeri, K.; Gelblum, D.; Chen, L.; Kriplani, A.; Wong, W.; Zhang, Z.; Lopez, A.; Wong, R. J.; Cracchiolo, J. R.; Sherman, E.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Exploring published and novel pre-treatment CT and PET radiomics to stratify risk of progression among early-stage non-small cell lung cancer patients treated with stereotactic radiation
    Journal Article

    Thor, M.; Fitzgerald, K.; Apte, A.; Hun Oh, J.; Iyer, A.; Odiase, O.; Nadeem, S.; Yorke, E. D.; Chaft, J.; Wu, A. J.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • A novel FDG PET and mean lung dose model to identify stage III NSCLC patients at high risk of developing early radiation pneumonitis
    Meeting Abstract

    Thor, M.; Shepherd, A. F.; Apte, A.; Gelblum, D.; Wu, A. J.; Simone, C. B. 2nd; Chaft, J.; Rimner, A.; Gomez, D. R.; Deasy, J. O.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Biomarkers associated with pulmonary exacerbations in a prospective, placebo-controlled, randomized trial of nintedanib for the treatment of radiation pneumonitis
    Meeting Abstract

    Moore, Z. R.; Huang, X.; Lobaugh, S.; Geyer, A.; Gelblum, D.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Chaft, J.; Zauderer, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Factors associated with outcomes in patients with metastatic NSCLC receiving osimertinib and consolidative radiation therapy
    Meeting Abstract

    Ma, J.; Yu, H.; Gelblum, D.; Kroen, E.; Shaverdian, N.; Tsai, C. J.; Yang, J. T.; Rimner, A.; Huang, J.; Gomez, D. R.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Treatment outcomes for radiation therapy with concurrent carboplatin and paclitaxel for locally advanced head and neck cancer
    Meeting Abstract

    Han, J.; Zakeri, K.; Raab, G.; Chen, L.; Yu, Y.; Kang, J. J.; McBride, S.; Riaz, N.; Tsai, C. J.; Gelblum, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Effects of tumor mutational burden and gene alterations associated with radiation response on outcomes of postoperative radiation therapy in non-small cell lung cancer
    Journal Article

    Shaverdian, N.; Shepherd, A. F.; Li, X.; Offin, M.; Lengel, H. B.; Gelblum, D. Y.; Wu, A. J.; Simone, C. B. 2nd; Rimner, A.; Jones, D. R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab
    Journal Article

    Thor, M.; Shepherd, A. F.; Preeshagul, I.; Offin, M.; Gelblum, D. Y.; Wu, A. J.; Apte, A.; Simone, C. B. 2nd; Hellmann, M. D.; Rimner, A.; more...
    Radiotherapy and Oncology (2022)

    Fulltext@MSK | Save
  • Pre-treatment immune-related markers predict disease outcomes in non-small cell lung cancer patients treated with chemoradiation and durvalumab
    Meeting Abstract

    Thor, M.; Shepherd, A. F.; Apte, A.; Offin, M.; Wu, A. J.; Gelblum, D.; Simone, C. B. 2nd; Rimner, A.; Gomez, D. R.; Deasy, J. O.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save